To profit from cannabis, you need to know this fascinating bit of history…

This is my kind of “Knight’s Tale.”

His name was William O’Shaughnessy, he was born in 1809, and he was a true Victorian-era renaissance man.

This is a man who pioneered the use of the telegraph, experimented with color photography, sparked research into intravenous therapies, and discovered the importance of electrolytes (Gatorade, anyone?) to human health.

But this Irish knight who trained in Scotland and worked in Calcutta for the British East India Co. was destined for an even greater achievement…

He got Western medicine to acknowledge the importance of cannabis to human health.

I’m sharing this intriguing bit of cannabis history here today for a key reason.

My “Knight’s Tale” is experiencing a new dawn. The medical cannabis saga has come full circle.

And as a guy who spent 26 years in the world of finance and investment banking, I can tell you that big shifts in innovation and legalization fueled by billions in new money flows have blasted open the biggest wealth window I’ve seen in decades.

So today, I’m going to tell you the rest of this “Knight’s Tale.”

Because the gospel that O’Shaughnessy started nearly two centuries ago got a big boost from the voters in one key state.

And that crusade has turned into a rush for wealth not seen in generations…

My Kind of Cannabis “Knight’s Tale”

First, let me tell you a little more about William O’Shaughnessy’s fascinating story.

He earned his medical degree from the University of Edinburgh in 1829, plunged into important research, and emigrated to India in 1833. While there, he saw firsthand how Cannabis Indica was employed as folk medicine for treating arthritis and spasms in infants.

He went on to develop cannabis as a treatment for spasticity in general, using cannabis resin to treat the wrenching muscle spasms for patients suffering from rabies and tetanus.

With his return to England in 1841, O’Shaughnessy became an evangelist for medical cannabis. He started to publish his research. And doctors throughout the West – including those here in America – started incorporating marijuana into their treatment regimens.

Call it “The Cannabis Medical Gospel According to William O’Shaughnessy.”

By 1850, you could find cannabis in medical preparations in pharmacies across the United States.

In the decades that followed, cannabis was a common, readily accepted therapy. By 1930, big pharma firms like Eli Lilly and Co. were actually cultivating huge fields of marijuana to manufacture cannabis-based drugs.

Then came “Reefer Madness,” the 1936 exploitation flick that supercharged what had been a slowly growing, anti-cannabis sentiment – demonizing it as the “Marijuana Menace” and setting the stage for seven-plus decades of regulation, politicization, and criminalization.

Which now brings us to a more recent bit of cannabis history.

Laying the Groundwork for Legal Cannabis

In 1994, California state legislators passed a bill legalizing cannabis for medical use. But then-Gov. Pete Wilson (R-CA) shot it down by veto.

In 1995, it happened again.

Fed up with asking permission from politicians, cannabis advocates said, “screw it.” They took a ballot initiative directly to voters. And on November 5, 1996, the Compassionate Use Act became law – making cannabis legal medicine once again.

By 2000, another seven states had passed medical cannabis laws – and only one was passed by legislators. By now, it was clear that bottom-up, direct initiatives from citizens were the best way for people to get what they wanted.

And that movement has put legal cannabis within reach of 97% of the population.

Today, 46 states plus Washington D.C. have laws that allow for the sale of cannabis.

The groundwork for giving people what they want has been laid virtually all across the country.

States are primed to take the next big revenue-boosting step.

And that step will easily double the size of the cannabis market twice in the next three years.

With So Much to Gain, Legalizing Recreational Cannabis Is Irresistible

Of the 46 states that have legalized marijuana sales, only 12 of those states, plus D.C., have gone fully recreational – meaning they allow sales to all adults.

But going recreational can boost a market three to five times. That means a three to five times larger tax base and a lot more jobs.

With so much to gain, the progression from medical to recreational is irresistible.

Even with mostly medical sales, the legal cannabis market has managed to grow at about 35% per year.

With the road cleared in most states, that rate of growth can easily jump to 45% – and 45% sales growth means the market doubles twice over the next three years. Which, frankly, will end up looking like a conservative estimate.

That’s because this progression from medical to recreational doesn’t require a thing from Congress.

They don’t have to reschedule cannabis. They don’t have to legalize cannabis. They don’t have to do anything other than stay out of the way – which means massive profits for those companies set up to meet this explosion in demand for cannabis.

And for investors in companies like Curaleaf Holdings Inc. (OTC: CURLF), now the biggest cannabis company in the world, the opportunity to build life-changing wealth from this rapid acceleration in growth could never be better.

Because today, many of the top cannabis companies can still be had for under $10 a share – but not for long.

Take care,

Don Yocham
Executive Director, National Institute for Cannabis Investors


Comments

4 responses to “How This Irish Knight “Invented” Gatorade, Pioneered Medical Cannabis – And Will Make You a Pot Stock Millionaire”

  1. I remember seeing a documentary years ago about cannabis. Allegedly, J. Edgar Hoover had a hand in demonizing the ‘evil weed’. The movie ‘Reefer Madness’ collided with all the really bad guys like Capone, Dillinger and Machine Gun Kelly either dead or behind bars.
    J. Edgar needed something to justify his agency’s continued existence. Enter the FDA declaring cannabis a tier 1 drug. The stage was set for the FBI to go after itinerant farm workers while making marijuana public enemy number 1. NOTE: I have no fact check info. to verify the above.

    • Hi Judy,

      Currently IIPR pays a dividend of $4.68 with a yield of 3.57%.

      It will be a little while before other cannabis companies pay a dividend because they are currently using the money they are bringing in to expand and grow their businesses. As the companies mature, they will start to think about paying out a dividend.

Leave a Reply

Your email address will not be published. Required fields are marked *